ZAGREB, July 28 (Hina) - The US company Barr Pharmaceuticals said on Friday its European branch had submitted to the Croatian Agency for the Supervision of Financial Services (HANFA) a formal offer for the purchase of 100 per cent of
shares of the Croatian drugs company Pliva.
ZAGREB, July 28 (Hina) - The US company Barr Pharmaceuticals said
on Friday its European branch had submitted to the Croatian Agency for the
Supervision of Financial Services (HANFA) a formal offer for the purchase of
100 per cent of shares of the Croatian drugs company Pliva. The US
company said that in accordance with the Croatian law on the takeover of joint
stock companies and HANFA instructions, Barr is prohibited from any discussions
about the amount and details of its offer until receiving HANFA's approval and
officially publishing the offer's terms in the Croatian media.
Under Croatian law, HANFA has a fortnight to give its opinion on the
offer.
Pliva's shares today reached a record high 814 kuna per share on the
Zagreb Stock Exchange.